oxybutynin chloride immediate-release
Drugcapsule containing oxybutynin chloride immediate-release 5 mg tablet administered three times daily, and placebo gel administered once daily
NCT Number: NCT00752141
The purpose of this study is to explore the possible cognitive effects of oxybutynin tablets and oxybutynin gel.
Looking for future studies?
Notify Me60 year–79 year
All sexes
Interventional
Phase 1
Tucson, Arizona, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other protocol-defined inclusion/exclusion criteria may apply
capsule containing oxybutynin chloride immediate-release 5 mg tablet administered three times daily, and placebo gel administered once daily
oxybutynin chloride topical gel applied once daily, and capsule containing placebo tablet administered three times daily
capsule containing placebo tablet administered three times daily, and placebo gel administered once daily
Time frame: one week
Time frame: one week
Looking for future studies?
Notify MeWatson Pharmaceuticals
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06299410
Healthy Volunteers
New Haven, Connecticut, United States
View Trial DetailsNCT07771959
Child Development, Healthy Volunteers
Dongchuan, Yunnan, China
View Trial DetailsNCT07390721
Healthy Volunteers, Physical Fitness
Bursa, Ağrı, Turkey (Türkiye)
View Trial DetailsNCT01517100
Glucose Metabolism Disorders, Healthy Volunteers
Baltimore, Maryland, United States
View Trial Details